Zimmer Biomet Holdings (ZBH) Ratios
Zimmer Biomet Holdings Ratios
MX:ZBH's free cash flow for Q2 2026 was $331.40M. For the 2026 fiscal year, MX:ZBH's free cash flow was decreased by $-116.40M and operating cash flow was $447.80M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.98 | 1.91 | 1.61 | 1.88 | 1.41 |
| Quick Ratio | 1.10 | 0.99 | 0.78 | 0.97 | 0.79 |
| Cash Ratio | 0.23 | 0.21 | 0.15 | 0.16 | 0.11 |
| Solvency Ratio | 0.17 | 0.21 | 0.22 | 0.13 | 0.12 |
| Operating Cash Flow Ratio | 0.66 | 0.61 | 0.55 | 0.54 | 0.43 |
| Short-Term Operating Cash Flow Coverage | 2.89 | 1.74 | 1.76 | 2.36 | 0.93 |
| Net Current Asset Value | $ -5.27B | $ -4.22B | $ -4.40B | $ -4.61B | $ -5.91B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.33 | 0.29 | 0.27 | 0.27 | 0.30 |
| Debt-to-Equity Ratio | 0.59 | 0.50 | 0.46 | 0.47 | 0.56 |
| Debt-to-Capital Ratio | 0.37 | 0.33 | 0.32 | 0.32 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.35 | 0.30 | 0.28 | 0.30 | 0.30 |
| Financial Leverage Ratio | 1.82 | 1.71 | 1.72 | 1.75 | 1.85 |
| Debt Service Coverage Ratio | 2.38 | 1.96 | 1.98 | 1.95 | 0.88 |
| Interest Coverage Ratio | 4.65 | 5.90 | 6.35 | 4.23 | 4.13 |
| Debt to Market Cap | 0.42 | 0.29 | 0.23 | 0.21 | 0.27 |
| Interest Debt Per Share | 39.45 | 31.62 | 28.60 | 27.96 | 34.89 |
| Net Debt to EBITDA | 3.12 | 2.52 | 2.41 | 3.56 | 4.07 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.62% | 71.46% | 71.82% | 70.90% | 71.29% |
| EBIT Margin | 13.65% | 16.34% | 17.16% | 8.19% | 10.36% |
| EBITDA Margin | 26.94% | 29.31% | 30.03% | 21.54% | 24.10% |
| Operating Profit Margin | 16.55% | 16.74% | 17.28% | 10.03% | 12.60% |
| Pretax Profit Margin | 10.09% | 13.50% | 14.43% | 5.81% | 7.31% |
| Net Profit Margin | 8.57% | 11.77% | 13.85% | 3.33% | 5.88% |
| Continuous Operations Profit Margin | 8.57% | 11.79% | 13.86% | 4.20% | 6.53% |
| Net Income Per EBT | 84.88% | 87.19% | 95.94% | 57.35% | 80.48% |
| EBT Per EBIT | 60.99% | 80.63% | 83.53% | 57.95% | 58.00% |
| Return on Assets (ROA) | 3.05% | 4.23% | 4.76% | 1.10% | 1.71% |
| Return on Equity (ROE) | 5.55% | 7.25% | 8.20% | 1.93% | 3.17% |
| Return on Capital Employed (ROCE) | 6.64% | 6.80% | 6.85% | 3.72% | 4.30% |
| Return on Invested Capital (ROIC) | 5.48% | 5.68% | 6.28% | 2.61% | 3.56% |
| Return on Tangible Assets | 8.37% | 11.56% | 13.09% | 3.12% | 4.46% |
| Earnings Yield | 3.96% | 4.21% | 4.03% | 0.87% | 1.56% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.83 | 5.19 | 5.13 | 5.02 | 5.42 |
| Payables Turnover | 10.43 | 11.26 | 5.08 | 5.70 | 6.40 |
| Inventory Turnover | 1.38 | 0.98 | 0.87 | 0.94 | 0.91 |
| Fixed Asset Turnover | 3.73 | 3.75 | 3.59 | 3.71 | 3.72 |
| Asset Turnover | 0.36 | 0.36 | 0.34 | 0.33 | 0.29 |
| Working Capital Turnover Ratio | 3.46 | 3.87 | 3.87 | 3.98 | 3.46 |
| Cash Conversion Cycle | 304.70 | 410.32 | 417.07 | 396.74 | 410.20 |
| Days of Sales Outstanding | 75.58 | 70.38 | 71.20 | 72.66 | 67.34 |
| Days of Inventory Outstanding | 264.13 | 372.35 | 417.79 | 388.08 | 399.93 |
| Days of Payables Outstanding | 35.00 | 32.42 | 71.92 | 64.00 | 57.07 |
| Operating Cycle | 339.70 | 442.73 | 488.99 | 460.74 | 467.27 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.57 | 7.38 | 7.58 | 6.13 | 7.19 |
| Free Cash Flow Per Share | 7.44 | 5.63 | 5.69 | 5.09 | 6.46 |
| Dividend Paid and CapEx Coverage Ratio | 4.09 | 2.71 | 2.66 | 3.07 | 4.26 |
| Capital Expenditure Coverage Ratio | 7.56 | 4.20 | 4.01 | 5.90 | 9.86 |
| Operating Cash Flow Coverage Ratio | 0.23 | 0.24 | 0.27 | 0.23 | 0.21 |
| Operating Cash Flow to Sales Ratio | 0.21 | 0.20 | 0.21 | 0.19 | 0.22 |
| Free Cash Flow Yield | 8.27% | 5.33% | 4.67% | 3.99% | 5.24% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 25.26 | 23.74 | 24.80 | 115.49 | 64.01 |
| Price-to-Sales (P/S) Ratio | 2.16 | 2.79 | 3.43 | 3.85 | 3.77 |
| Price-to-Book (P/B) Ratio | 1.40 | 1.72 | 2.04 | 2.22 | 2.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.09 | 18.78 | 21.40 | 25.04 | 19.08 |
| Price-to-Operating Cash Flow Ratio | 10.49 | 14.31 | 16.06 | 20.80 | 17.15 |
| Price-to-Earnings Growth (PEG) Ratio | -1.26 | -2.53 | 0.07 | -2.69 | -0.16 |
| Enterprise Value Multiple | 11.15 | 12.05 | 13.85 | 21.44 | 19.69 |
| Enterprise Value | 24.73B | 27.13B | 30.75B | 32.04B | 32.40B |
| EV to EBITDA | 11.15 | 12.05 | 13.85 | 21.44 | 19.69 |
| EV to Sales | 3.00 | 3.53 | 4.16 | 4.62 | 4.75 |
| EV to Free Cash Flow | 16.79 | 23.75 | 25.90 | 30.03 | 24.05 |
| EV to Operating Cash Flow | 14.57 | 18.10 | 19.44 | 24.94 | 21.61 |
| Tangible Book Value Per Share | -9.89 | -5.28 | -5.69 | -7.71 | -8.56 |
| Shareholders’ Equity Per Share | 64.13 | 61.39 | 59.80 | 57.35 | 60.69 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.15 | 0.13 | 0.04 | 0.28 | 0.11 |
| Revenue Per Share | 41.57 | 37.81 | 35.43 | 33.11 | 32.73 |
| Net Income Per Share | 3.56 | 4.45 | 4.91 | 1.10 | 1.93 |
| Tax Burden | 0.85 | 0.87 | 0.96 | 0.57 | 0.80 |
| Interest Burden | 0.74 | 0.83 | 0.84 | 0.71 | 0.71 |
| Research & Development to Revenue | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| SG&A to Revenue | 0.39 | 0.38 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| Income Quality | 2.41 | 1.66 | 1.54 | 4.41 | 3.37 |
Currency in USD